Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C118559 |
1-bromopropane |
1-bromopropane results in decreased expression of DRD2 mRNA | decreases expression | 19576243
|
C062458 |
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol |
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C062458 |
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol |
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C062458 |
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol |
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to DRD2 protein | affects binding | 10700011
|
C062458 |
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol |
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10683862
|
C104750 |
3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole |
3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 10728880
|
C086335 |
(5,6-dimethoxyindan-2-yl)dipropylamine |
(5,6-dimethoxyindan-2-yl)dipropylamine binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 10728880
|
C051171 |
5-methoxy-1-methyl-2-(n-propylamino)tetralin |
5-methoxy-1-methyl-2-(n-propylamino)tetralin binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 10728880
|
C031349 |
7-hydroxy-2-N,N-dipropylaminotetralin |
7-hydroxy-2-N,N-dipropylaminotetralin binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C031349 |
7-hydroxy-2-N,N-dipropylaminotetralin |
7-hydroxy-2-N,N-dipropylaminotetralin binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C031349 |
7-hydroxy-2-N,N-dipropylaminotetralin |
7-hydroxy-2-N,N-dipropylaminotetralin binds to DRD2 protein | affects binding | 10700011
|
C090812 |
7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan |
7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 10728880
|
C090812 |
7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan |
7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10683862
|
C090812 |
7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan |
7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan binds to DRD2 protein | affects binding | 10700011
|
C081320 |
8-(3-chlorostyryl)caffeine |
DRD2 protein affects the susceptibility to 8-(3-chlorostyryl)caffeine | affects response to substance | 11172060
|
C081320 |
8-(3-chlorostyryl)caffeine |
DRD2 protein affects the susceptibility to [8-(3-chlorostyryl)caffeine co-treated with Reserpine] | affects cotreatment|affects response to substance | 11172060
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DRD2 mRNA | affects expression | 16483693
|
D000661 |
Amphetamine |
DRD2 SNP affects the susceptibility to Amphetamine | affects response to substance | 19968402
|
D000661 |
Amphetamine |
Amphetamine results in increased expression of DRD2 mRNA | increases expression | 16916582
|
D000661 |
Amphetamine |
Amphetamine results in increased expression of DRD2 mRNA alternative form | increases expression | 17026527
|
D000661 |
Amphetamine |
CACNA1D protein affects the reaction [Amphetamine results in increased expression of DRD2 mRNA alternative form] | affects reaction|increases expression | 17026527
|
D000661 |
Amphetamine |
Amphetamine results in decreased expression of DRD2 mRNA | decreases expression | 15183010 19145071
|
D000661 |
Amphetamine |
Amphetamine results in decreased expression of DRD2 protein | decreases expression | 19145071
|
C094645 |
aripiprazole |
aripiprazole binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 17069544
|
D001280 |
Atrazine |
Atrazine affects the activity of DRD2 protein | affects activity | 11071396
|
D001464 |
Barium |
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [DRD2 protein results in decreased transport of Barium] | decreases reaction|decreases transport | 11124974
|
D001464 |
Barium |
[DRD2 protein affects the abundance of Calcium] which results in decreased transport of Barium | affects abundance|decreases transport | 11124974
|
D001464 |
Barium |
DRD2 protein affects the reaction [N-n-propylnorapomorphine analog results in decreased transport of Barium] | affects reaction|decreases transport | 11124974
|
D001464 |
Barium |
DRD2 protein affects the reaction [Quinpirole results in decreased transport of Barium] | affects reaction|decreases transport | 11124974
|
D001464 |
Barium |
DRD2 protein results in decreased transport of Barium | decreases transport | 11124974
|
D001464 |
Barium |
[DRD2 protein results in increased activity of PLCB1 protein] which results in decreased transport of Barium | decreases transport|increases activity | 11124974
|
D001464 |
Barium |
Nifedipine inhibits the reaction [DRD2 protein affects the reaction [Quinpirole results in decreased transport of Barium]] | affects reaction|decreases reaction|decreases transport | 11124974
|
C039108 |
benzo(f)quinoline |
benzo(f)quinoline analog binds to DRD2 protein | affects binding | 19053758
|
D001971 |
Bromocriptine |
Bromocriptine results in decreased expression of DRD2 mRNA | decreases expression | 15781964
|
D001971 |
Bromocriptine |
Bromocriptine results in increased expression of DRD2 mRNA | increases expression | 15781964
|
D001971 |
Bromocriptine |
[Clozapine co-treated with Bromocriptine] results in decreased expression of DRD2 mRNA | affects cotreatment|decreases expression | 15781964
|
D001971 |
Bromocriptine |
Bromocriptine promotes the reaction [Clozapine results in decreased expression of DRD2 mRNA] | decreases expression|increases reaction | 15781964
|
D001971 |
Bromocriptine |
Bromocriptine results in decreased expression of DRD2 mRNA | decreases expression | 15781964
|
D001971 |
Bromocriptine |
Bromocriptine binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10683862
|
D002110 |
Caffeine |
DRD2 protein results in increased susceptibility to Caffeine | increases response to substance | 11172060
|
D002118 |
Calcium |
[DRD2 protein affects the abundance of Calcium] which results in decreased transport of Barium | affects abundance|decreases transport | 11124974
|
D002220 |
Carbamazepine |
Carbamazepine results in decreased expression of DRD2 protein | decreases expression | 16478526
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of DRD2 mRNA | increases expression | 16644059
|
C012145 |
CF 25397 |
CF 25397 binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10683862
|
C051347 |
CGS 15855A |
CGS 15855A binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C051347 |
CGS 15855A |
CGS 15855A binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
D002749 |
Chlorprothixene |
Chlorprothixene analog binds to DRD2 protein | affects binding | 8101879
|
D002749 |
Chlorprothixene |
Chlorprothixene binds to DRD2 protein | affects binding | 8101879
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in decreased expression of DRD2 mRNA | decreases expression | 17452286
|
D003024 |
Clozapine |
Clozapine binds to DRD2 protein | affects binding | 11997696
|
D003024 |
Clozapine |
DRD2 gene affects the susceptibility to Clozapine | affects response to substance | 15830237
|
D003024 |
Clozapine |
DRD2 gene polymorphism affects the susceptibility to Clozapine | affects response to substance | 16278074
|
D003024 |
Clozapine |
Clozapine binds to DRD2 protein alternative form | affects binding | 12476322
|
D003024 |
Clozapine |
[Clozapine co-treated with Bromocriptine] results in decreased expression of DRD2 mRNA | affects cotreatment|decreases expression | 15781964
|
D003024 |
Clozapine |
Clozapine results in decreased expression of DRD2 mRNA | decreases expression | 17266109
|
D003024 |
Clozapine |
Bromocriptine promotes the reaction [Clozapine results in decreased expression of DRD2 mRNA] | decreases expression|increases reaction | 15781964
|
D003024 |
Clozapine |
Clozapine analog binds to DRD2 protein | affects binding | 11997696
|
D003024 |
Clozapine |
Clozapine binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 16033416
|
D003024 |
Clozapine |
[Clozapine binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein | affects binding|decreases activity|increases expression | 16033416
|
D003024 |
Clozapine |
Clozapine promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D003024 |
Clozapine |
Clozapine results in decreased expression of DRD2 mRNA | decreases expression | 15781964
|
D003024 |
Clozapine |
DRD2 protein affects the reaction [Clozapine results in increased expression of CTNNB1 protein] | affects reaction|increases expression | 16144542
|
D003024 |
Clozapine |
DRD2 protein affects the reaction [Clozapine results in increased expression of DVL3 protein] | affects reaction|increases expression | 16144542
|
D003024 |
Clozapine |
DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3A protein] | affects reaction|increases expression | 16144542
|
D003024 |
Clozapine |
DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3B protein] | affects reaction|increases expression | 16144542
|
D003024 |
Clozapine |
DRD2 protein affects the susceptibility to Clozapine | affects response to substance | 11997696
|
C007168 |
cyanazine |
cyanazine affects the activity of DRD2 protein | affects activity | 11071396
|
C017160 |
cypermethrin |
cypermethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
C017180 |
decamethrin |
decamethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D003976 |
Diazinon |
Diazinon affects the expression of DRD2 mRNA | affects expression | 18812211
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in increased expression of DRD2 mRNA | increases expression | 15620428
|
D004006 |
Dichlorvos |
Dichlorvos results in decreased activity of DRD2 protein | decreases activity | 12186780
|
D004006 |
Dichlorvos |
Nimodipine inhibits the reaction [Dichlorvos results in decreased activity of DRD2 protein] | decreases activity|decreases reaction | 12186780
|
D004298 |
Dopamine |
Dopamine binds to DRD2 protein alternative form | affects binding | 12476322
|
D004298 |
Dopamine |
Clozapine promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D004298 |
Dopamine |
cypermethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D004298 |
Dopamine |
DBH protein affects the reaction [Dopamine binds to DRD2 protein] | affects binding|affects reaction | 15716360
|
D004298 |
Dopamine |
decamethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D004298 |
Dopamine |
Dopamine binds to DRD2 protein | affects binding | 15716360
|
D004298 |
Dopamine |
Dopamine promotes the reaction [Oxidopamine binds to DRD2 protein] | affects binding|increases reaction | 16480889
|
D004298 |
Dopamine |
DRD4 protein affects the reaction [Dopamine binds to DRD2 protein] | affects binding|affects reaction | 15716360
|
D004298 |
Dopamine |
estradiol 3-benzoate inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D004298 |
Dopamine |
Ethanol affects the reaction [Dopamine binds to DRD2 protein] | affects binding|affects reaction | 15716360
|
D004298 |
Dopamine |
GRK6 protein affects the reaction [Dopamine binds to DRD2 protein] | affects binding|affects reaction | 15716360
|
D004298 |
Dopamine |
Haloperidol inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D004298 |
Dopamine |
Haloperidol promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D004298 |
Dopamine |
olanzapine promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D004298 |
Dopamine |
quetiapine promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D004298 |
Dopamine |
[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine | affects binding|increases activity|increases uptake | 10936494
|
D004298 |
Dopamine |
[Raclopride binds to and results in decreased activity of DRD2 protein] which results in increased abundance of Dopamine | affects binding|decreases activity|increases abundance | 15341276
|
D004298 |
Dopamine |
Risperidone promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D004298 |
Dopamine |
tautomycin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D004298 |
Dopamine |
Tea inhibits the reaction [Dopamine promotes the reaction [Oxidopamine binds to DRD2 protein]] | affects binding|decreases reaction|increases reaction | 16480889
|
C074283 |
estradiol 3-benzoate |
estradiol 3-benzoate inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D000431 |
Ethanol |
Ethanol affects the reaction [Dopamine binds to DRD2 protein] | affects binding|affects reaction | 15716360
|
D000431 |
Ethanol |
Ethanol results in increased expression of DRD2 mRNA | increases expression | 18713641
|
D005231 |
Fatty Acids, Unsaturated |
Fatty Acids, Unsaturated deficiency results in decreased expression of DRD2 mRNA | decreases expression | 11916751
|
D005231 |
Fatty Acids, Unsaturated |
Fatty Acids, Unsaturated deficiency results in increased expression of DRD2 mRNA | increases expression | 11916751
|
D005473 |
Fluoxetine |
Fluoxetine results in decreased expression of DRD2 mRNA | decreases expression | 11981225
|
C408390 |
GR 218231 |
GR 218231 binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 10728880
|
D006220 |
Haloperidol |
Haloperidol binds to DRD2 protein | affects binding | 11997696
|
D006220 |
Haloperidol |
DRD2 protein affects the susceptibility to Haloperidol | affects response to substance | 11172060
|
D006220 |
Haloperidol |
Haloperidol binds to DRD2 protein alternative form | affects binding | 12476322
|
D006220 |
Haloperidol |
DRD2 protein affects the reaction [Haloperidol results in increased expression of CTNNB1 protein] | affects reaction|increases expression | 16144542
|
D006220 |
Haloperidol |
DRD2 protein affects the reaction [Haloperidol results in increased expression of DVL3 protein] | affects reaction|increases expression | 16144542
|
D006220 |
Haloperidol |
DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3A protein] | affects reaction|increases expression | 16144542
|
D006220 |
Haloperidol |
DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3B protein] | affects reaction|increases expression | 16144542
|
D006220 |
Haloperidol |
Haloperidol binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 16033416
|
D006220 |
Haloperidol |
[Haloperidol binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein | affects binding|decreases activity|increases expression | 16033416
|
D006220 |
Haloperidol |
Haloperidol inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D006220 |
Haloperidol |
Haloperidol promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of DRD2 protein | increases expression | 18295747
|
D006220 |
Haloperidol |
Haloperidol binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 19482038 15945060
|
D016627 |
Oxidopamine |
Dopamine promotes the reaction [Oxidopamine binds to DRD2 protein] | affects binding|increases reaction | 16480889
|
D016627 |
Oxidopamine |
Tea inhibits the reaction [Dopamine promotes the reaction [Oxidopamine binds to DRD2 protein]] | affects binding|decreases reaction|increases reaction | 16480889
|
D008090 |
Lisuride |
Lisuride binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10683862
|
D008094 |
Lithium |
Lithium results in decreased expression of DRD2 protein | decreases expression | 16478526
|
D008152 |
Loxapine |
Loxapine binds to DRD2 protein | affects binding | 8101879
|
D008728 |
Methotrimeprazine |
Methotrimeprazine binds to DRD2 protein | affects binding | 8101879
|
D008787 |
Metoclopramide |
Metoclopramide binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 1930352
|
C035133 |
mirtazapine |
mirtazapine inhibits the reaction [Quinpirole binds to DRD2 protein] | affects binding|decreases reaction | 12523492
|
D009020 |
Morphine |
Morphine results in increased expression of DRD2 mRNA | increases expression | 17063042
|
D009020 |
Morphine |
Morphine results in decreased expression of DRD2 mRNA | decreases expression | 15183518
|
C521676 |
N-((2,2-dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)-benzylamine |
N-((2,2-dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)-benzylamine binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 19695244
|
C097285 |
nafadotride |
nafadotride binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 10728880
|
C068868 |
naltrindole benzofuran |
naltrindole benzofuran binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 19482038
|
C407426 |
neurotensin 69L |
neurotensin 69L results in increased expression of DRD2 mRNA | increases expression | 17113052
|
D009543 |
Nifedipine |
Nifedipine inhibits the reaction [DRD2 protein affects the reaction [Quinpirole results in decreased transport of Barium]] | affects reaction|decreases reaction|decreases transport | 11124974
|
D009553 |
Nimodipine |
Nimodipine inhibits the reaction [Dichlorvos results in decreased activity of DRD2 protein] | decreases activity|decreases reaction | 12186780
|
C009074 |
N-n-propylnorapomorphine |
DRD2 protein affects the reaction [N-n-propylnorapomorphine analog results in decreased transport of Barium] | affects reaction|decreases transport | 11124974
|
C025256 |
nonylphenol |
nonylphenol results in increased expression of DRD2 mRNA | increases expression | 15620428
|
C076029 |
olanzapine |
olanzapine promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D010269 |
Paraquat |
Paraquat affects the expression of DRD2 mRNA | affects expression | 15206577
|
D010622 |
Phencyclidine |
Phencyclidine results in decreased expression of DRD2 mRNA | decreases expression | 17266109
|
D010891 |
Piribedil |
Piribedil binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
D010891 |
Piribedil |
Piribedil binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C061333 |
pramipexol |
pramipexol binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C061333 |
pramipexol |
pramipexol binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C061333 |
pramipexol |
pramipexol binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10683862
|
D001498 |
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester |
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [DRD2 protein results in decreased transport of Barium] | decreases reaction|decreases transport | 11124974
|
C069541 |
quetiapine |
quetiapine promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
C047726 |
quinelorane |
quinelorane binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C047726 |
quinelorane |
quinelorane binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10728880
|
C047726 |
quinelorane |
quinelorane binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 10683862
|
D017378 |
Quinolinic Acid |
Quinolinic Acid results in increased expression of DRD2 protein | increases expression | 12207953
|
D019257 |
Quinpirole |
Quinpirole binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 15725338
|
D019257 |
Quinpirole |
Quinpirole binds to and results in increased activity of DRD2 protein | affects binding|increases activity | 14622157
|
D019257 |
Quinpirole |
cypermethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D019257 |
Quinpirole |
decamethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D019257 |
Quinpirole |
DRD2 protein affects the reaction [Quinpirole results in decreased transport of Barium] | affects reaction|decreases transport | 11124974
|
D019257 |
Quinpirole |
estradiol 3-benzoate inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D019257 |
Quinpirole |
Haloperidol inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D019257 |
Quinpirole |
mirtazapine inhibits the reaction [Quinpirole binds to DRD2 protein] | affects binding|decreases reaction | 12523492
|
D019257 |
Quinpirole |
Nifedipine inhibits the reaction [DRD2 protein affects the reaction [Quinpirole results in decreased transport of Barium]] | affects reaction|decreases reaction|decreases transport | 11124974
|
D019257 |
Quinpirole |
[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine | affects binding|increases activity|increases uptake | 10936494
|
D019257 |
Quinpirole |
tautomycin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D020891 |
Raclopride |
DRD2 protein alternative form results in increased susceptibility to Raclopride | increases response to substance | 12476322
|
D020891 |
Raclopride |
Raclopride binds to DRD2 protein alternative form | affects binding | 12476322
|
D020891 |
Raclopride |
DRD2 protein affects the reaction [Raclopride results in increased expression of CTNNB1 protein] | affects reaction|increases expression | 16144542
|
D020891 |
Raclopride |
DRD2 protein affects the reaction [Raclopride results in increased expression of GSK3A protein] | affects reaction|increases expression | 16144542
|
D020891 |
Raclopride |
Raclopride binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 15341276 15542624 19289156 16144542
|
D020891 |
Raclopride |
[Raclopride binds to and results in decreased activity of DRD2 protein] which results in increased abundance of Dopamine | affects binding|decreases activity|increases abundance | 15341276
|
D020891 |
Raclopride |
Raclopride binds to DRD2 protein | affects binding | 7901417
|
D017330 |
Remoxipride |
Remoxipride binds to DRD2 protein | affects binding | 7901417
|
D012110 |
Reserpine |
DRD2 protein affects the susceptibility to [8-(3-chlorostyryl)caffeine co-treated with Reserpine] | affects cotreatment|affects response to substance | 11172060
|
D018967 |
Risperidone |
Risperidone binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 16948927
|
D018967 |
Risperidone |
DRD2 protein affects the reaction [Risperidone results in increased expression of CTNNB1 protein] | affects reaction|increases expression | 16144542
|
D018967 |
Risperidone |
DRD2 protein affects the reaction [Risperidone results in increased expression of DVL3 protein] | affects reaction|increases expression | 16144542
|
D018967 |
Risperidone |
DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3A protein] | affects reaction|increases expression | 16144542
|
D018967 |
Risperidone |
DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3B protein] | affects reaction|increases expression | 16144542
|
D018967 |
Risperidone |
Risperidone binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 16033416
|
D018967 |
Risperidone |
[Risperidone binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein | affects binding|decreases activity|increases expression | 16033416
|
D018967 |
Risperidone |
Risperidone promotes the reaction [Dopamine binds to DRD2 protein] | affects binding|increases reaction | 15716360
|
D013134 |
Spiperone |
Spiperone binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 15725338
|
D013134 |
Spiperone |
NR3C1 protein promotes the reaction [Spiperone binds to DRD2 protein] | affects binding|increases reaction | 11226678
|
D013134 |
Spiperone |
Spiperone binds to DRD2 protein | affects binding | 11226678
|
C010513 |
stepholidine |
stepholidine binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 18521575
|
C053079 |
tautomycin |
tautomycin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] | affects binding|decreases reaction|increases activity|increases uptake | 10936494
|
D013662 |
Tea |
Tea inhibits the reaction [Dopamine promotes the reaction [Oxidopamine binds to DRD2 protein]] | affects binding|decreases reaction|increases reaction | 16480889
|
D013881 |
Thioridazine |
Thioridazine binds to DRD2 protein | affects binding | 8101879
|
C050504 |
tianeptine |
tianeptine results in decreased expression of DRD2 mRNA | decreases expression | 11981225
|
D014147 |
Tramadol |
Tramadol results in increased expression of DRD2 protein | increases expression | 15464068
|
C045971 |
UH 232 |
UH 232 binds to and results in decreased activity of DRD2 protein | affects binding|decreases activity | 10728880
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of DRD2 protein | decreases expression | 16478526
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
10.30 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
10.30 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
10.30 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.26 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.04 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.04 | 11192467 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.34 | 14617031 16160616 12649775 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
23.84 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
23.84 | 17119214 16611668 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
cypermethrin |
23.84 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
23.84 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Dichlorvos |
23.84 | 16611668 12661182 17119214 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
23.84 | 11874814 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.57 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
3.27 | 19621015 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.48 | 17688650 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.32 | 16459022 16916582 18475255 15010207 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.10 | 15513904 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
8.79 | 12183048 12005258 16101753 16084549 |
MESH:D000855 |
Anorexia |
|
Quinpirole |
8.79 | 12183048 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
11.56 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Fluoxetine |
11.56 | 18083778 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
11.56 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Reserpine |
5.15 | 10729376 |
MESH:D020817 |
Asperger Syndrome |
|
aripiprazole |
9.68 | 19519261 |
MESH:D020817 |
Asperger Syndrome |
|
Risperidone |
9.68 | 16401163 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
aripiprazole |
11.03 | 17069544 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Oxidopamine |
11.03 | 14699433 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Risperidone |
11.03 | 18349709 |
MESH:D001321 |
Autistic Disorder |
|
aripiprazole |
6.11 | 17069544 |
MESH:D001321 |
Autistic Disorder |
|
Fluoxetine |
6.11 | 19232924 18775368 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
6.11 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
mirtazapine |
6.11 | 16648008 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
6.11 | 17069543 18685284 |
MESH:D001321 |
Autistic Disorder |
|
Quinolinic Acid |
6.11 | 16139734 |
MESH:D001321 |
Autistic Disorder |
|
Risperidone |
6.11 | 17929164 16379507 15994720 19368416 19232924 17069546 15492353 16239862 16601648 18026891 18278980 16948927 18080171 18349709 15930063 19013209 17019624 19154706 18775368 16730335 15543515 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
6.11 | 17507914 18396377 15238991 19460635 18558336 19232924 20603192 17688650 18985861 18177632 18316065 16609825 18775368 18940202 17157402 |
MESH:D001480 |
Basal Ganglia Diseases |
|
Bromocriptine |
11.07 | 15303389 |
MESH:D001480 |
Basal Ganglia Diseases |
|
Dichlorvos |
11.07 | 15303389 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
13.55 | 20046352 17594078 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
13.55 | 20338123 20046352 17594078 19153942 |
MESH:D001714 |
Bipolar Disorder |
|
Risperidone |
13.55 | 18278980 19154706 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
13.55 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
2.89 | 8888407 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
4.42 | 19211983 |
MESH:D001943 |
Breast Neoplasms |
|
Reserpine |
4.50 | 11921183 |
MESH:D002056 |
Burns |
|
Ethanol |
3.94 | 16374292 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.07 | 15700767 16011737 15721981 16124888 18705752 16050911 15673190 16097048 16227642 10355542 3786805 16192424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
2.73 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
2.73 | 15763234 18788625 15289165 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
2.99 | 19332462 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.18 | 1977408 15215559 |
MESH:D002389 |
Catatonia |
|
olanzapine |
5.50 | 18071103 16772815 |
MESH:D002418 |
Cattle Diseases |
|
Dichlorvos |
4.91 | 14651886 |
MESH:D002493 |
Central Nervous System Diseases |
|
Dichlorvos |
5.04 | 12670839 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
aripiprazole |
5.59 | 19519261 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
5.59 | 20734317 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.15 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
2.82 | 15513904 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.25 | 17123785 |
MESH:D003128 |
Coma |
|
Dichlorvos |
5.25 | 15303389 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
4.55 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
decamethrin |
4.55 | 19861644 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
4.55 | 15451039 19302082 15451040 10194807 15513904 11198716 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
4.55 | 8888407 16575769 17688650 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
4.75 | 16037377 |
MESH:D007644 |
Darier Disease |
|
Lithium |
5.18 | 20338123 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
14.66 | 20210726 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Risperidone |
14.66 | 20210726 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Thioridazine |
14.66 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
13.11 | 11575062 |
MESH:D003704 |
Dementia |
|
Risperidone |
13.11 | 11575062 |
MESH:D003704 |
Dementia |
|
Thioridazine |
13.11 | 11575062 |
MESH:D003866 |
Depressive Disorder |
|
Fluoxetine |
7.15 | 15014590 |
MESH:D003866 |
Depressive Disorder |
|
mirtazapine |
7.15 | 18083778 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.16 | 17069543 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.03 | 19244398 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
2.76 | 16402076 |
MESH:D003967 |
Diarrhea |
|
Morphine |
3.85 | 2540324 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
11.96 | 15331141 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Risperidone |
11.96 | 16379507 |
MESH:D053207 |
Diurnal Enuresis |
|
Risperidone |
5.93 | 17822346 |
MESH:D004314 |
Down Syndrome |
|
Risperidone |
4.51 | 18349709 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
4.73 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
3.92 | 16538176 20216337 15057820 16538175 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
8.99 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.99 | 16227642 7179309 19085960 11566570 21278145 15027814 10092053 3732212 6884620 6623471 17522070 15998439 4309450 7120509 2869522 3786805 15968718 19336974 10915739 7440962 16177239 9327722 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
8.99 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tea |
8.99 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
8.99 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
3.89 | 20216337 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.63 | 16402076 |
MESH:D004415 |
Dyspepsia |
|
Metoclopramide |
6.97 | 8218764 |
MESH:D004417 |
Dyspnea |
|
cypermethrin |
8.49 | 16487989 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
8.49 | 16487989 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.37 | 1851702 |
MESH:D004487 |
Edema |
|
Fluoxetine |
3.76 | 12798668 |
MESH:D020803 |
Encephalitis, Herpes Simplex |
|
Quinolinic Acid |
6.08 | 17174341 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
4.04 | 17654737 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
4.56 | 19915237 18855540 16538176 16415921 20485159 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
8.82 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
8.82 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
7.91 | 16628512 15008574 17116037 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
7.91 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
5.62 | 17178248 821787 18234410 19620853 7988514 9014606 20417680 19700373 17465707 19439326 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
5.62 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
2.96 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
9.33 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
9.33 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
8.46 | 3659116 15276670 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
8.46 | 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
4.99 | 19549232 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.53 | 16704527 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
4.73 | 20485159 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
4.87 | 19890266 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
9.44 | 15959796 16045604 61145 16239168 19224547 17595544 12795759 12631006 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
9.44 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
9.44 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
4.92 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.56 | 15513904 10194807 15451040 16946407 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.14 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.43 | 8888407 18558336 |
MESH:D005329 |
Fetishism (Psychiatric) |
|
mirtazapine |
6.57 | 18439117 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
2.75 | 18705752 |
MESH:D005756 |
Gastritis |
|
Ethanol |
3.95 | 15046732 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.42 | 11124998 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
3.78 | 19638421 |
MESH:D006505 |
Hepatitis |
|
Caffeine |
16.87 | 11394713 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
16.87 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
cypermethrin |
16.87 | 16487989 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
16.87 | 16487989 |
MESH:D006561 |
Herpes Simplex |
|
Chlorprothixene |
5.39 | 1682908 |
MESH:D006734 |
Horse Diseases |
|
Dichlorvos |
5.25 | 16402567 |
MESH:D019584 |
Hot Flashes |
|
Fluoxetine |
4.57 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.13 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.13 | 18783367 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.80 | 16899240 |
MESH:D006941 |
Hyperesthesia |
|
Dichlorvos |
5.94 | 12563396 |
MESH:D006943 |
Hyperglycemia |
|
Risperidone |
4.52 | 18278980 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.10 | 10459572 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
9.37 | 1977408 14960337 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
9.37 | 16046005 |
MESH:D006951 |
Hyperlipoproteinemias |
|
Fatty Acids, Unsaturated |
5.52 | 18435438 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
5.49 | 17933447 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
4.50 | 18773962 |
MESH:D006973 |
Hypertension |
|
Nifedipine |
3.92 | 20102058 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.37 | 15338365 |
MESH:D007022 |
Hypotension |
|
Dopamine |
4.34 | 6740701 |
MESH:D007035 |
Hypothermia |
|
Reserpine |
5.57 | 1977408 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
8.46 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
8.46 | 16466525 12948887 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
8.46 | 4850670 |
MESH:D007249 |
Inflammation |
|
Fluoxetine |
3.47 | 12798668 |
MESH:D007299 |
Insect Bites and Stings |
|
cypermethrin |
10.72 | 15189238 |
MESH:D007299 |
Insect Bites and Stings |
|
decamethrin |
10.72 | 15189238 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
3.74 | 15513904 |
MESH:D007674 |
Kidney Diseases |
|
Dichlorvos |
3.80 | 16798900 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.30 | 16316344 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.50 | 15451040 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.00 | 16294345 17596541 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.26 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
10.42 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Fluoxetine |
10.42 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Thioridazine |
10.42 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.29 | 16943688 17334410 11408273 21278145 16221502 11903743 17174718 17157831 16239168 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
5.29 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.36 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.37 | 18277467 17900296 12445418 18166357 17823541 15959796 12666154 10355542 15370692 18481824 14512876 17944888 15730626 12958196 14716496 15362042 18210741 13678700 15673190 15057751 16248980 15123356 14748882 15052691 17869086 15931870 15925388 16033810 18472332 17976157 14620537 12741479 18006644 17631135 12389079 12609069 17698563 18205269 15818738 16116963 12632514 15996030 17761835 16011737 12649538 17766677 18054572 15650968 15338365 12632512 17481882 17565644 17805973 18279442 16136751 17922224 18472094 15893842 16015684 20821823 17708605 14724832 16027843 18263696 18418968 18705752 15876570 12586293 17721639 18339082 18395914 18395095 18156304 18187930 17557913 16638106 18376398 16097048 18412020 18420326 17640975 16192424 18429990 11481614 17525996 18317297 12667390 14716833 18251166 12898905 17714472 12546737 12445421 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
2.37 | 18166357 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
5.36 | 16964402 17285989 15830285 16246199 15720792 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
5.36 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
cypermethrin |
5.36 | 15991261 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
3.94 | 17347304 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.45 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.04 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
1.93 | 19294768 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
2.15 | 15583823 12014681 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
7.32 | 20210726 |
MESH:D008133 |
Long QT Syndrome |
|
Thioridazine |
7.32 | 20210726 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.52 | 17228818 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.31 | 16628512 |
MESH:D016778 |
Malaria, Falciparum |
|
Chlorprothixene |
9.53 | 16882315 |
MESH:D016778 |
Malaria, Falciparum |
|
Thioridazine |
9.53 | 16882315 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
estradiol 3-benzoate |
5.69 | 15375486 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Reserpine |
5.69 | 11921183 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.50 | 15451040 18411066 |
MESH:D001523 |
Mental Disorders |
|
aripiprazole |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Chlorprothixene |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Fluoxetine |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Methotrimeprazine |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
mirtazapine |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
quetiapine |
45.10 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Risperidone |
45.10 | 16596465 16856516 |
MESH:D001523 |
Mental Disorders |
|
Thioridazine |
45.10 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
aripiprazole |
8.20 | 16891339 17069544 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
8.20 | 9014606 |
MESH:D008607 |
Mental Retardation |
|
Risperidone |
8.20 | 18349709 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.18 | 1916698 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
4.72 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
8.14 | 19142101 |
MESH:D024821 |
Metabolic Syndrome X |
|
Risperidone |
8.14 | 19142101 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.65 | 18803445 18765137 |
MESH:D019964 |
Mood Disorders |
|
Risperidone |
5.11 | 17019624 |
MESH:D016472 |
Motor Neuron Disease |
|
Dichlorvos |
5.59 | 11282359 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.36 | 8888407 |
MESH:D009175 |
Mycoplasma Infections |
|
Chlorprothixene |
6.08 | 10773494 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.69 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
3.57 | 16288908 |
MESH:C536096 |
Myoclonic dystonia |
marker/mechanism |
|
| |
MESH:D009207 |
Myoclonus |
|
Fluoxetine |
5.14 | 8041377 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
4.73 | 20399394 |
MESH:D009349 |
Nematode Infections |
|
Dichlorvos |
5.39 | 16402567 |
MESH:D009410 |
Nerve Degeneration |
|
Dichlorvos |
7.07 | 11282359 17850875 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
7.07 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
4.22 | 16990009 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
2.62 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
15.39 | 15183010 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Dichlorvos |
15.39 | 16635102 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Nimodipine |
15.39 | 16635102 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Oxidopamine |
15.39 | 18514411 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
7.02 | 15081274 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Dichlorvos |
7.02 | 12186780 |
MESH:D053206 |
Nocturnal Enuresis |
|
Risperidone |
5.58 | 17822346 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.57 | 19142110 18515891 |
MESH:D009765 |
Obesity |
|
olanzapine |
4.57 | 18515891 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Fluoxetine |
4.78 | 20418887 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
4.73 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.29 | 17882678 |
MESH:D010146 |
Pain |
|
Carbamazepine |
11.46 | 15215642 |
MESH:D010146 |
Pain |
|
Fluoxetine |
11.46 | 12798668 |
MESH:D010146 |
Pain |
|
Morphine |
11.46 | 16273134 20225289 6776300 18699797 15215642 15275824 |
MESH:D010146 |
Pain |
|
Tramadol |
11.46 | 18204346 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.66 | 12384795 |
MESH:D010195 |
Pancreatitis |
|
Dichlorvos |
4.23 | 16258382 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
4.98 | 16538176 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
9.78 | 17218051 |
MESH:D010300 |
Parkinson Disease |
|
Bromocriptine |
9.78 | 9918342 18328768 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
9.78 | 12911755 15451049 16510128 11445065 11181820 16140633 15824117 11124998 |
MESH:D010300 |
Parkinson Disease |
|
pramipexol |
9.78 | 15178694 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Dichlorvos |
14.61 | 12645970 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Oxidopamine |
14.61 | 11771942 15893579 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
14.61 | 16190885 |
MESH:D020734 |
Parkinsonian Disorders |
marker/mechanism |
|
| 12476322 |
MESH:D020734 |
Parkinsonian Disorders |
|
Raclopride |
5.19 | 12476322 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.19 | 17679678 17145499 |
MESH:D020774 |
Pick Disease of the Brain |
|
Fluoxetine |
5.28 | 8041377 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
3.72 | 12504350 |
MESH:D011041 |
Poisoning |
|
Diazinon |
7.21 | 17603234 |
MESH:D011041 |
Poisoning |
|
Dichlorvos |
7.21 | 16036766 17603234 12460839 17157343 18072136 15303389 |
MESH:D011115 |
Polyneuropathies |
|
Dichlorvos |
4.90 | 12563396 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
4.44 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
7.67 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
7.67 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Dichlorvos |
5.08 | 12661182 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
10.12 | 9591791 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
10.12 | 12752131 11422049 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
9.44 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
9.44 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
aripiprazole |
21.27 | 16891339 |
MESH:D011618 |
Psychotic Disorders |
|
Chlorprothixene |
21.27 | 19708200 16882315 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
21.27 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
21.27 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Thioridazine |
21.27 | 16882315 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.58 | 17997886 16324872 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
3.72 | 19211983 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.23 | 11700416 |
MESH:D012131 |
Respiratory Insufficiency |
|
Dichlorvos |
4.95 | 17350689 15303389 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
17.16 | 11874814 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
17.16 | 16611668 17119214 11874814 |
MESH:D012135 |
Respiratory Sounds |
|
Dichlorvos |
17.16 | 16611668 17119214 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
17.16 | 11874814 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
8.78 | 16611668 17119214 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Dichlorvos |
8.78 | 16611668 17119214 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.30 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.49 | 19155313 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 18583979 11245917 |
MESH:D012559 |
Schizophrenia |
|
aripiprazole |
13.81 | 16891339 |
MESH:D012559 |
Schizophrenia |
|
Chlorprothixene |
13.81 | 1830565 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
13.81 | 17726453 20107430 16141801 20580759 17123785 20452607 18806925 11763009 11151749 18855531 17667964 20521326 20168265 20521320 19369910 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
13.81 | 20107430 1830565 18513383 19369910 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
13.81 | 17726453 20521326 20107430 |
MESH:D012559 |
Schizophrenia |
|
Risperidone |
13.81 | 20107430 19154706 18278980 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
13.81 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
13.04 | 16938433 16180713 9844417 15946322 9046859 19414003 16876388 |
MESH:D012640 |
Seizures |
|
Dichlorvos |
13.04 | 17157343 12660363 |
MESH:D012640 |
Seizures |
|
Ethanol |
13.04 | 9754883 |
MESH:D012640 |
Seizures |
|
Lithium |
13.04 | 19660546 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
13.04 | 11738929 11044598 16876388 14763951 17978042 1511512 15475178 3137016 |
MESH:D020230 |
Serotonin Syndrome |
|
Fluoxetine |
5.15 | 8704074 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.34 | 6418539 |
MESH:D012893 |
Sleep Disorders |
|
Caffeine |
14.04 | 19395429 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
14.04 | 19414003 |
MESH:D012893 |
Sleep Disorders |
|
Risperidone |
14.04 | 18278980 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Caffeine |
4.36 | 17225163 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.19 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
10.19 | 19951488 19430551 19570321 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
10.19 | 12833885 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
5.67 | 1977408 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
4.50 | 16538176 18855540 19915237 20485159 19694795 15057820 16415921 |
MESH:D013274 |
Stomach Neoplasms |
|
Dichlorvos |
2.94 | 11397402 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.94 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
5.88 | 17918041 17189318 11906479 9211565 16755016 9562338 |
MESH:D013276 |
Stomach Ulcer |
|
Nifedipine |
5.88 | 14653237 |
MESH:D013322 |
Strongyloidiasis |
|
Dichlorvos |
5.39 | 14651886 |
MESH:D013375 |
Substance Withdrawal Syndrome |
marker/mechanism |
|
| 17189962 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.61 | 9754883 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
19.12 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
19.12 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Risperidone |
19.12 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Thioridazine |
19.12 | 20210726 |
MESH:D005879 |
Tourette Syndrome |
|
Risperidone |
5.22 | 19154706 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.48 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
3.79 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
3.92 | 8888407 |
MESH:D014570 |
Urologic Diseases |
|
cypermethrin |
10.15 | 16487989 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
10.15 | 16487989 |
MESH:D015430 |
Weight Gain |
marker/mechanism |
|
| 20375926 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
12.98 | 17502770 20521320 16402076 20107430 20564506 16141801 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
12.98 | 17933447 19434072 20107430 |
MESH:D015430 |
Weight Gain |
|
Risperidone |
12.98 | 20564506 16379507 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.34 | 17933447 |